MELONEX 20

Each ml contains:
Meloxicam. 20 mg
Excipients. q.s.

Relief of acute and chronic pain associated with musculoskeletal disorders.
Reduction of pain and discomfort in cases of severe mastitis and laminitis.
Supportive treatment for BRD (Bovine Respiratory Disease) and fever reduction.
Management of post-operative pain and traumatic inflammatory conditions.
Used to reduce swelling and pain associated with foot rot.

Meloxicam provides its therapeutic benefits by inhibiting the production of prostaglandins, which are key chemical mediators of the inflammatory cascade. It works through the selective inhibition of the enzyme Cyclooxygenase-2 (COX-2). COX-2 is induced at sites of injury and is responsible for pain, heat, and swelling. By blocking COX-2, Meloxicam effectively reduces localized inflammatory signs and pyrexia. Its preference for COX-2 over the constitutive COX-1 enzyme helps minimize potential adverse effects on the gastrointestinal lining.

Concentrated dose (20 mg/ml) requires a significantly smaller injection volume.
Rapid reduction of pain and fever, improving animal comfort and welfare.
Selective COX-2 action provides a better safety profile.
Sustained relief often achieved with a single administration.
Enhances patient recovery and mobility during critical illness.

Cattle/Buffaloes (Adult): 1.0 ml per 100 kg body weight, Intravenous (I.V.) or Subcutaneous (S.C.)
Swine: 0.5 ml per 50 kg body weight, Intramuscular (I.M.)
Typically a single administration is sufficient; follow veterinary guidance for duration.

50 ml, 100 ml vial

Injection